← Back to headlines
Propanc Biopharma Authorizes $5M Share Buyback Program
Propanc Biopharma has authorized a $5 million share buyback program, leading to a surge in its shares.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
